With that in mind, we have studied pathways involving insulin, ghrelin, and GLP-1, he says
Based on preclinical studies, a systematic review of the neuroprotective mechanisms of GLP-1RA-based therapy in ischemic stroke [67] has shown that administration of drugs of this family before, during, or after an experimental stroke in animals with and without diabetes modulates an acute inflammatory response secondary to brain ischemia, reducing inflammation, endothelial dysfunction and excitotoxicity, as well as decreasing oxidative stress and apoptosis
Now we still are saying use GLP ones for what they are intended for, which is metabolic health and weight
Among those who do start using GLP-1s, over 50% stop due to costs , and as many as 36% stop due to side effects